Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease.
Journal of neuroinflammation 2019 Feb 16 (1): 50.
Redenšek Sara, Flisar Dušan, Kojovic Maja, Kramberger Milica Gregoric, Georgiev Dejan, Pirtošek Zvezdan, Trošt Maja, Dolžan Vi
No association between a promoter NOS1 polymorphism (rs41279104) and Infantile Hypertrophic Pyloric Stenosis.
Journal of human genetics 2009 Dec 54 (12): 706-8.
Lagerstedt-Robinson Kristina, Svenningsson Anna, Nordenskjöld Agne